Wendy Watson takes over Kaiser Foundation Health Plan and Hospitals of the Northwest, and Corwin N. Harper becomes president of Kaiser Foundation Health Plan of Georgia.
Wendy Watson
Effective Feb. 16, 2025, Wendy Watson will take over as president of Kaiser Foundation Health Plan and Hospitals of the Northwest. As regional president, she will lead the organization’s focus on providing healthcare and coverage for more than 612,000 members in Oregon and southwest Washington, as well as dental care and coverage for more than 285,000 members.
Watson is a 32-year veteran of Kaiser Permanente of the Northwest, serving the region most recently as chief operating officer. She joined Kaiser Permanente in 1993 and has held a variety of leadership roles across the spectrum of operations, care delivery, and hospital administration.
Watson holds a bachelor’s degree in molecular biology and a master’s degree in public health from Portland State University. She also completed an advanced fellowship with the Health Care Advisory Board in Washington, D.C., and an executive fellowship with the Baldrige Foundation.
She is a member of the board of directors for the Hospital Association of Oregon. Watson was named Executive of the Year by the Portland Business Journal in 2022 and has been honored with the Patriot Award by the U.S. Army for Employer Support of the Guard and Reserve.
Kaiser Foundation Health Plan and Hospitals is part of Kaiser Permanente, a not-for-profit health plan headquartered in Oakland, Calif., and serves 12.5 million members.
Corwin N. Harper
Additionally, Kaiser Permanente has appointed Corwin N. Harper president of Kaiser Foundation Health Plan of Georgia, effective Jan. 21, 2025. As regional health plan president, Harper will lead the organization’s focus on providing integrated, high-quality health care and coverage for more than 327,000 Kaiser Permanente members.
He brings brings 39 years of healthcare and hospital leadership experience to his position as regional president, including 25 years of previous experience at Kaiser Permanente. Most recently, he served as CEO of Ochsner LSU Health North Louisiana, an integrated academic health system with three acute care hospitals, a behavioral health hospital and 20 clinics with more than 600 students, residents and faculty.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Opzelura May Reduce Need for Other Treatments in Atopic Dermatitis | AAD 2025
March 11th 2025Patients with atopic dermatitis who had not received biologics prior to treatment with Opzelura were able to avoid biologics during the 12 months after treatment with the topical nonsteroidal, finds study at American Academy of Dermatology Association annual meeting.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Supporting Patients with Type 1 Diabetes Through Education, Technology and Transparency
March 10th 2025Arti Masturzo, M.D., chief medical officer of CCS, spoke with MHE in this third part of a video series to share how CCS helps patients with type 1 diabetes effectively use glucose monitors and insulin pumps by providing clear guidance and troubleshooting support, recognizing that even minor errors in management can have significant health consequences.
Read More
Melanoma Treatment Advances Now Crossing into Other Skin Cancers
March 10th 2025Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with advanced basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma, which is a rare and aggressive type of skin cancer.
Read More